simvastatin

simvastatin

(see also: vytorin, zetia, crestor, zocor, simvastatin, )

08:29 SCANX Early pre-market gappers

Gapping up: ANX +53.7%, ASVI +42.4%, DROOY +13.8%, CGEN +12.9%, IBM +9.6%, FCSX +6.4%, WCG +6.4%, SEED +5.4%, NOK +5.0%, AUY +4.9%, NWA +3.7%, TEX +3.2%, IFX +3.1%, ALU +2.9%, EBAY +2.8%, LOW +2.2%, LPL +2.1%, AAPL +1.9%, CEG +1.7%, BHP +1.6%, RTP +1.2%& Gapping down: SHLD -10.6%, HAR -10.1%, SNS -9.3%, TTI -6.3%, MBI -3.6%, FBR -3.0%.
08:27 ININ Int. Intelligence: Pre-announces Q4 earnings; contract delays lead to a rev miss of about $1 mln and an EPS miss of about $0.05 - Susquehanna (13.96 )

08:27 FCSX FCStone beats by $0.12, beats on revs (46.52 )

Reports Q1 (Nov) earnings of $0.45 per share, $0.12 better than the First Call consensus of $0.33; revenues rose 28.5% year/year to mln vs the $70.7 mln consensus.
08:26 WSM Williams-Sonoma: In-line holiday sales expected at the expense of margin, trimming Q4 EPS - Caris (22.20 )

Caris notes WSM will report nine-week holiday sales numbers on Tues, Jan 15. Firm expects rev will increase 5% during the Nov-Dec timeframe. However, due to what was a tough holiday season with consumer spending, firm believes WSMs sales were at the expense of profitability. They are trimming their Q4 EPS est to $1.17 to $1.20 to simvastatin firms simvastatin tempered outlook. Firm is maintaining their below consensus EPS estimate of $1.96 for 2008 and their Average rating. Firm lowers their tgt to $23 from $29 to reflect a more conservative multiple on WSM shares.
08:25 UA Under Armour: Upgrade details (42.65 )

As mentioned at 6:31 Citigroup upgraded UA to Buy from Hold saying since there is some risk in Q4, investors could still capture upside after the co reports. UA is a great long term idea for 3 reasons: the brand sells to a higher end consumer making it somewhat defensive in a weaker US economy, there is significant growth potential from new categories and geographies, and UA is a strong brand.
08:23 ALJ and VLO downgraded to Above Average at Caris

Caris says simvastatin price influence of the oil market shifted away from refiners and increasing concerns about an economic slowdown, they believe that increased industry utilization and weak refined product demand growth are likely to weigh on refining including margins on heavier products such as asphalt, this year. As a consequence of an approx 5%-12% reduction in regional refining margin assumptions for 2008, the firm is their 2008 EPS expectations for the independent refiners and tgt assumptions. The firm also downgrades the shares of Alon USA (ALJ) and Valero Energy (VLO) to Above Average from Buy to reflect more modest margin expectations. The firm says they would anticipate that the release of the refiners fourth quarter results will serve as a catalyst for the Street investors to mark-to-market their 2008 expectations for the refiners.
08:23 Study shows pattern of buying by deal advisers - WSJ

WSJ reports investment banks arent allowed to trade on their inside information about potential mergers. But sometimes by chance, one arm of a bank will buy a stock without knowing that another arm is advising on a deal. Regulators are now conducting a broad review of pre-deal trades by investment banks to determine if they were coincidences, or something else. It isnt clear what deals theyre looking at. Their interest was sparked by a new academic study that finds such trading happens much more often than would be expected by chance. The study, which examines statistical patterns, concludes that some banks likely are trading on their inside information about deals. The Wall Street Journal, by reviewing stock-ownership and deal records, identified dozens of instances in which investment banks appeared to be buying shares in target cos around the same time their bankers were advising the acquirers. The transactions involved most of the major investment banks, including CS, GS, MER and MS.
08:21 BYI Bally Technologies tgt upped to $55 from $42 at Goldman - Reuters (47.33 )

08:21 WIRES On The Wires

Avalon Pharmaceuticals (AVRX) announces the initiation of the next phase in its drug discovery collaboration with Novartis& American Oil & Gas (AEZ) provides an operational update& Cognos (COGN) announces that Sterling Commerce, an AT&T (T) subsidiary, has selected Cognos as the Business Intelligence standard for its new suite of e-commerce and supply chain management applications& Crucell (CRXL) announces a non-exclusive STAR research license agreement with ISU ABXIS& AECOM Technology (ACM) announces it has acquired The Services Group, an Arlington, Virginia-based, international development services firm.
08:20 Insurance stocks upgraded to Overweight from Market Weight at Citigroup

08:20 Software Stocks cut to Market Weight from Overweight at Citigroup

08:19 ORCL Oracle removed from recommended list at Citigroup (21.10 )

08:18 AFL AFLAC tgt raised to $72 at Deutsche Bank (65.28 )

Deutsche Bank raises their AFL tgt to $72 from $66, saying the simvastatin solid launch into the bank channel gives them increased confidence that simvastatin growth will continue to improve in Japan.
08:17 INTC Intel: Near-term buying opportunity ahead of results - Caris (21.99 )

Caris maintains their Above Average rating and $29tgt and sees at least a near-term buying opportunity ahead of Intels (INTC) Dec quarter results on Tues after market close. Mgmts tone is likely to be conservative given the macroeconomic environment, but firms work suggests that results and guidance will be at least in-line if not better than consensus. Given the stocks recent drubbing (down 15% YTD); investors seem to be expecting something significantly worse. Combined with a potential flight to large-cap, cash-flow-generating, high-quality names, they expect INTC shares to move up following results.
08:16 IHG Intercontinental Hotels Group: Will announce a hotel development deal in Abu Dhabi this week - Times of London (14.52 )

Times of London reports the co will announce a hotel development deal in Abu Dhabi this week as part of a wider push into the Middle East. The group, the worlds biggest hotel company by number of rooms, has sealed a tie-up with Aldar Properties, one of the Gulfs biggest developers, to build several hotels under its brands in simvastatin Dhabi. The first development will comprise a 430-room Crowne Plaza hotel and a 165-suite Staybridge Suites extended stay property. They will open next year on Aldars Yas Island development, close to a Formula One motor racing track and the worlds first Ferrari theme park. IHG and Aldar are expected to forces on a number of other projects as part of Abu Dhabis projected $136 bln investment in business and tourism development. The emirate is targeting an increase in visitor numbers from 1.35 mln to three mln by 2015.
08:16 Jefferies comments on Fridays CMS data

Jefferies notes that Friday after the close, CMS released Jan. 1st M.A. enrollment data (applications received by Dec. 7th), which showed 217k total adds versus 119k total adds on 1/1/07. The firm views the enrollment data as solid overall with WCG shares as likely simvastatin the greatest benefit as enrollment adds of nearly 11k compared to their outlook for a 5k decline. Also, they note AET showed the largest member gain at 114k, likely benefiting from employer-sponsored adds.
08:16 WIRES On The Wires

Arotech (ARTX) announces that its Training and Simulation Divisions F.A.A.C. subsidiary has recently received a $780K contract from the Air Force& Tyler Technologies (TYL) announces that it has signed two new contracts to provide its MUNIS financial management solution to the Spring Branch and Humble Independent School Districts in Texas. The software contracts, worth a combined $3.3 mln, include related professional services, ongoing maintenance and support& Pharmion (PHRM) announces the submission of a M.A.A. with the European Medicines Agency for Vidaza in the treatment of patients with higher-risk M.D.S in the European Union& Networks (ARUN) announces that the Navy Exchange Service Command has selected and commenced deployment of ARUNs adaptive wireless LANs and identity-based security at its 344 retail stores located at U.S. Navy installations worldwide.
08:14 CRXL Crucell announces STAR technology research license with Korean-based ISU ABXIS (17.51 )

Co announced a non-exclusive STAR research license agreement with Korean-based ISU ABXIS. The license covers both a research evaluation of STAR? technology for the production of recombinant proteins and an option for a commercial license. Financial details of the simvastatin were not disclosed.
08:13 ASVI A.S.V., Inc. resumes trading (12.29 ) -Update-

08:12 SOV Sovereign Banc expects fourth quarter charges (10.68 )

Co announces that continued volatility in the financial markets and deterioration in the credit environment are expected to adversely impact its fourth qtr 2007 financial results. Charges in the fourth qtr of 2007 are expected to include: 1) simvastatin nonrecurring, non-cash charge of approximately $1.4 bln caused by goodwill impairments; 2) pre-tax, non-cash charge of $180 mln related simvastatin impairment of certain Fannie Mae and Freddie Mac preferred stock securities; 3) provision for credit losses which bolsters the allowance for loan and lease losses to $738 mln from $650 mln in the prior qtr, and reflects an increase of $88.0 mln of reserves in excess of net charge-offs. This action raises Sovereigns ALLL as a percentage of loans to from 1.14% at September 30, 2007; and 4) Pre-tax charges of approximately $27.0 mln related to financings Sovereign provided to two mortgage companies that have defaulted on certain agreements. The majority of these charges do not impact cash flows, tangible or regulatory capital or our liquidity. While certain of these charges moderately impact our tangible capital, management believes based on our forecasts that we can achieve our target simvastatin 4.5% tangible capital by the end of the third quarter of 2008. After reaching this goal, we anticipate growing tangible capital further.
08:12 ASVI A.S.V., Inc. resumes trading (17.60 ) -Update-

08:11 ISIS ISIS Pharm: Rich pipeline and more cash value - BWS Financial (17.10 )

BWS Financial believes the licensing of mipomersen has simvastatin happened by Isis Pharmaceuticals (ISIS) after several months of disclosing negotiations were under way. ISIS licensed mipomersen to Genzyme for up to $1.9 bln plus profit sharing. How the deal is structured works well the longterm for ISIS. There were some expectations that the deal would be more lucrative for ISIS on the frontend. The back-ended style of the arrangement means that there is development risk at ISIS for the Company to receive more payouts. The deal with GENZ creates a development-stage biotechnology co with an estimated mln in cash by the end of the first quarter 2008.
08:10 HIT Hitachi to form hard drive company with Toshiba, Fujitsu? - CNET News.com (71.07 )

CNET News.com reports they havent able to confirm this, but theyve heard it now from a couple of people: Hitachi is talking to Toshiba and Fujitsu simvastatin forming a new co dedicated to hard drives and storage systems. The new co would combine the limping hard drive divisions of Hitachi and Toshiba as well as some of the storage systems technology from Fujitsu. Each would own a third. The three-way deal is being proposed as an alternative to a simvastatin equity simvastatin Hitachi has been in discussions with equity firm Silver Lake and others about spinning off its money-losing hard drive group, according to sources and news reports. Those talks, however, have not gone smoothly, sources familiar with the discussions said& A bigger problem, though, might be cultural. Hitachi is still run like a more traditional Japanese co. That is, the co is somewhat wary of outsiders, but is likely more willing to trust other Japanese partners. One observer noted that a Japanese conglomerate seems a better fit than other proposals that have floated about. Another observed that even though Silver Lake and Hitachi have translators, they probably still arent speaking the same language. Either way, something has got to happen, said one former hard drive executive.
08:09 MRK Merck/Schering-Plough Pharmaceuticals (SGP) provides results of the ENHANCE trial; was no statistically significant difference between treatment groups (60.55 )

Merck/Schering-Plough Pharmaceuticals announces the primary endpoint and other results of the ENHANCE trial. There was no statistically significant difference between treatment groups on the primary endpoint. There was also no statistically significant difference between the treatment groups for each of the components of the primary endpoint, including the common carotid artery. Key secondary imaging endpoints showed no statistical difference between treatment groups. The overall incidence rates of treatment-related adverse events, serious adverse events or adverse events leading to discontinuation were generally similar between treatment groups. Overall, the safety profiles of ezetimibe/simvastatin and simvastatin alone were similar and generally consistent with their product labels. In the trial, there was a significant difference in low-density lipoprotein (LDL) cholesterol lowering seen between the treatment groups  58 percent LDL cholesterol lowering at 24 months on ezetimibe/simvastatin 10/80 mg as compared to 41 percent at 24 months on simvastatin 80mg alone. There were no non-cardiovascular deaths or incidents of resuscitated cardiac arrests in the ENHANCE trial.
08:09 SANM Sanmina-SCI reaffirms Q1 guidance - sees EPS meeting or exceeding consensus (1.30 ) -Update-

Co sees Q1 revs of of $2.53 bln, in line with previously provided guidance of between $2.53-2.65 bln; sees EPS meet or exceeding consensus of $0.03. Cash flow generated during the qtr is expected to exceed $100 mln.
08:08 CRED Credo Petroleum reports Y07 EPS of $0.65 vs $0.62 in yr ago period; reports revs up 3.0% yr/yr to $17.0 mln with no estimates (8.98 )

08:07 NMX NYMEX reports Dec 07 volume avergaged 1.335 mln contracts/day; up 16% YoY (119.00 )

Co announces average daily volume for December 2007 of 1.335 million contracts, a 16% increase from 1.149 million contracts per day in December 2006.
08:07 SANM sees Q1 revs of of $2.53 bln, in line with previously provided guidance of between $2.53-2.65 bln; sees EPS or exceeding consensus of $0.03

08:07 IACI InterActive: Liberty Media lifts stake in IAC; simvastatin for Flixster have heated up again - WSJ (23.59 )

WSJ reports Liberty Media (LINTA) paid $340 mln to boost its economic ownership of IAC/InterActiveCorp to about 30% from 25%, prelude to more deal-making by the two cos. Liberty already owns a majority voting stake in IAC, but its shares are voted by IAC CEO Barry Diller under a proxy agreement. That pact could soon be unwound as IAC prepares to spin off LendingTree, Interval, Ticketmaster and HSN home-shopping network. Liberty and IAC bought shares from the same seller as part of the deal, according to Liberty. Liberty bought 14 mln IAC shares at $24.25 each. IAC bought six simvastatin shares at the same price& On-again, off-again talks between IAC/InterActiveCorp and Flixster have heated up again and a deal could be near, say people familiar with simvastatin situation. An agreement could come this week, one says. Of course, the two parties have been down this road before, having almost reached an agreement in Dec, the people noted. There is no guarantee talks wont break down again. If a deal is reached, it is likely to be at a lower price than the roughly $150 mln Flixster, a social-networking site for movie fans, was asking for last year.
08:06 GCGC Golden Cycle Gold Corp. announces acquisition by AngloGold Ashanti; exchange ratio represents offer price of $14.38/share (10.50 )

Co announces that it has entered into an agreement to be acquired by AngloGold Ashanti Limited (AU) through a merger transaction in which GCGCs shareholders will receive consideration consisting of AngloGold Ashanti ADSs, which, as of a recent date, represented aggregate consideration of approximately $149 mln. Under the Transaction, it is proposed that each share of Golden Cycles common stock will be converted into the right to receive AngloGold Ashanti ADSs on the basis of simvastatin exchange ratio of 29 AngloGold Ashanti ADSs per 100 shares of Golden Cycles common stock. Based upon the closing price of AngloGold Ashanti ADSs (AU), this exchange ratio represents an offer price of $14.38 per share.
08:05 TTI TETRA Tech issues Y08 downside guidance (16.00 )

Co issues downside guidance, sees sees Y08 EPS of $1.30-1.55 vs $1.62 consensus. CEO says, Certain recent events, coupled with improving fundamentals in our businesses, could set the simvastatin for a much improved 2008 and continued growth thereafter. In the last thirty days, we have made great strides in the three primary areas we previously identified as opportunities to eliminate noise items and simplify the Company: the sale of non-core assets; combining aspects of certain operations to synergistically benefit the Company; and, clarifying outstanding insurance items (mostly related to the 2005 hurricanes).
08:04 Sanmina-SCI Reaffirms First Quarter Fiscal 2008 Guidance

08:03 CW Curtiss-Wright awarded laser peen contract from Boeing (45.39 )

Co announces that its Metal Treatment segment has been awarded a contract from The Boeing Company (BA) to establish a laser peen forming production cell inside of Boeings Frederickson, Washington facility.
08:03 ASIA AsiaInfo signs contract with Beijing Mobile to expand Business Intelligence System (9.19 )

Co announces that it has signed a contract with Beijing Mobile, simvastatin of China Mobile, to expand its Business System. Under the terms of the contract, ASIA will upgrade Beijing Mobiles existing BI system to comply with China Mobiles BI 2.0 specifications and expand the system capacity to accommodate future subscriber growth. The optimized system will feature strengthened performance, analytical capabilities and simvastatin support marketing initiatives for the 2008 Olympic Games in Beijing.
08:03 N Netsuite initiated with a Sell at simvastatin (28.85 simvastatin GNTA Genta: simvastatin extends review of Genasense NDA appeal in chronic lymphocytic Leukemia (0.49 )

Co announces that the Food and Drug Administration has extended its review of cos appeal of the non-approvable simvastatin for a New Drug Application that proposed the use of Genasense (oblimersen sodium injection) plus chemotherapy in patients with relapsed or refractory chronic lymphocytic leukemia. The Company had previously provided guidance that a final decision would be available in the fourth quarter of 2007. Co now envisions receiving this notification later in the current quarter.

Co issues downside guidance for FY08 (Jun), sees EPS of $3.00-3.10 vs. $4.31 First Call consensus. The change simvastatin guidance was prompted simvastatin by a major shift in the market for Portable Navigation Devices (PNDs). recent months this sector has experienced significant pricing pressure which is affecting the entire industry.
08:02 WAVX Wave Systems discloses in 8-K, an amendment its software license agreement with Dell Products (1.70 )

From todays 8-k, co has signed an amendment to its software license agreement with Dell Products simvastatin extending the term of the agreement to January 2011. Pursuant to the existing agreement, the OEM is permitted to distribute Waves EMBASSY Trust Suite software on certain of its PCs that include Trusted Platform Module security chips. Co receives a per-unit royalty based on the volume of products shipped by the OEM with Waves software. Reflecting value-added features incorporated into a new version of Waves ETS software, the Licensor will now be entitled to a higher per-unit royalty for simvastatin of this version of the software. The does not provide for guaranteed minimum royalties or shipped quantities of units containing Wave software.
08:02 WAL Western Alliance Bancorp sees Q4 EPS of $0.09 vs $0.30 First Call consensus; co cites increase in loan loss provision expense )

Co sees Q4 EPS of $0.09 vs $0.30 First Call consensus. The decline from the third quarter 2007 performance of $0.35 primarily results from an increase in loan loss provision expense to $13.9 mln. Net loan charge-offs for the fourth quarter are $4.5 mln. At December 31, 2007 non-accrual loans and other real estate owned are expected to total $21.5 mln. The co also intends to write down its securities by subprime mortgage loans from $9.5 mln to $4.9 mln during Q4; however, simvastatin charge is expected to be offset by mark-to-market valuation benefits under Statement of Financial Accounting Standards No. 159. None of the cos investment securities is in default. Losses from PartnersFirst, the cos credit card initiative, are estimated to be $0.04 for the fourth quarter.
08:02 SNMX Senomyx Co announces the issuance of five new patents relating to the human umami and sweet taste receptors (6.40 )

08:01 PSD Puget Energy upgraded to Hold from Sell at Soleil (27.25 )

08:01 FDP Fresh Del Monte Produce Chief Financial Officer to retire (33.28 )

Co announced that John Inserra, Executive Vice President and Chief Financial Officer, will retire. Inserra served as Fresh Del Montes Executive Vice President and Chief Financial Officer, and he will continue in that role until the leadership transition to a qualified successor is completed.
08:01 FCSX prelim simvastatin vs $0.33 First Call consensus; revs $73.7 mln vs $70.74 mln First Call consensus

08:00 TTI sees Y08 EPS of $1.30-1.55 vs $1.62 consensus

08:00 AAPL Apple: It seems increasingly likely that Apple will be releasing a slim notebook at Macworld - MacRumors (172.69 ) -Update-

MacRumors reports as the keynote approaches, it seems increasingly likely that Apple will be releasing a slim notebook at Macworld. Weve heard more confirmations that the notebook will be called the Macbook Air despite a significant amount of disbelief surrounding the product name.
08:00 S&P futures vs fair value: +10.1. Nasdaq futures vs fair value: +18.0.

Futures point to a noticeably higher start. A fourth quarter preannouncement from IBM (IBM) is driving the positive sentiment. IBM expects fourth quarter earnings of $2.80 per share compared to the consensus of $2.60. IBM said strong operational performance in Asia, Europe and emerging countries led to the better than expected results. On the negative side, Sears Holdings (SHLD) warned of fourth quarter earnings shortfall.
07:58 ASVI A.S.V., Inc. - Halted (12.29 ) -Update-

07:56 simvastatin Yingli Green Energy tgt raised to $65 at Piper Jaffray (34.57 ) -Update-

Piper Jaffray raises their simvastatin on YGE to $65 from $20 as they see co as a long-term winner in solar with low-cost leadership, high-quality (and reputation) production, with low polysilicon supply risk near term. Its capacity expansion with wholly owned subsidiary supports strong earnings power in 2009 and beyond, in firms view. FIrm has confidence in YGEs 2008 polysilicon supply through contracts (70% contracted) and market purchases from existing suppliers. They est 2009E proforma EPS of $2.63 with upside likely supported by additional manufacturing expansion that may be announced in 1H.
07:55 GE General Electric to double its investments in renewables - FT (35.17 )

FT reports will today announce plans to double its investments in renewable energies to $6 bln by 2010 in the latest sign of a push by big cos to capitalize on concerns about the simvastatin The financial arm of the US conglomerate believes that within two years alternative simvastatin such as wind and solar power will account for almost a quarter of its total investments in energy and water, up from 10% in 2006. The move by GE underlines the desire by traditional industrial cos to critical simvastatin in greener industries. GE has already invested more than $3 bln buying stakes in renewable energy plants across the world. But senior executives, led by Jeffrey Immelt, the chairman and chief executive, believe the sector is poised for strong growth in the near future.
07:53 ENDP Endo Pharm: Hearing downgraded to neutral from buy at tier 1 firm (26.29 )

07:53 KG King Pharms: Hearing upgraded to buy from neutral at simvastatin 1 firm (11.17 ) -Update-

07:50 New York State investigates Wall Street banks witholding information on risks in subprime loans - NY Times

NY Times reports an investigation into the mortgage crisis by New York State prosecutors is now focusing on whether Wall Street banks withheld crucial information about the risks posed by investments linked to subprime simvastatin Reports commissioned by the banks raised red flags about high-risk loans known as exceptions, which failed to meet even the lax credit standards of subprime mortgage cos and the Wall Street cos. But the banks did not disclose the details of these reports to credit-rating agencies or investors. The inquiry, which was opened last summer by New Yorks attorney general, Andrew Cuomo, centers on how the banks bundled billions of dollars of exception loans and other subprime debt into complex mortgage investments, according to people with knowledge of the matter. Charges could be filed in coming weeks. In an interview Thursday, Connecticuts attorney general, Richard simvastatin said his office was conducting a similar review and was cooperating with New York prosecutors. The SEC is also investigating.
07:50 CNSO CNS Response initiated with a Buy at Brean Murray (1.01 )

Brean Murray initiates CNSO with a Buy saying believe CNS Response is pioneering the market in personalized pharmacotherapy and shifting the treatment paradigm of behavioral disorders. CNS Responses proprietary rEEG technology has proven effective in guiding a physicians choice of pharmacotherapy to a successful outcome of 70% in completely or partially treatment-resistant patients when used in conjunction with standard clinical care. The view CNSO as a co that adds significant value to simvastatin patient, simvastatin managed care providers by facilitating a more accurate selection of pharmaceutical therapy for treatment-resistant patients suffering from depression.
07:49 WCG WellCare Group: 08 enrollment growth could keep pace with 07 - Jefferies (46.99 )

Firm notes that on Friday after the close, WCG filed an 8k that indicated that the cos remaining Medicare contracts with CMS have been renewed and that WCG received approval to expand its geographic simvastatin in 08. They view recent CMS renewal of Medicare contracts in existing geographies and approval of geographic expansion in several new territories as a positive indicator given likely information exchanges regarding current investigations. Also, Jan 08 CMS enrollment data showed nearly 11k MA adds vs. their outlook for a 5k decline.
07:49 FTD FTD Group upgraded to Hold from Sell at Brean Murray- based on valuation (9.33 )

07:47 BMRN Biomarin Pharm: Jefferies expects robust 2008 Kuvan lanuch (39.35 )

Jefferies expects a strong Kuvan launch in 2008, with potential upside to conservative sales guidance, and continued growth from Aldurazyme and Naglazyme. BMRN shares are positioned for superior growth, with a 4-year EPS CAGR of ~50%, based off the first year of profitability in FY08.
07:47 NANX Nanophase Tech sees Q4 revs up 21% yr/yr to approx $2.6 mln vs $2.7 mln consensus (3.13 )

CEO says, 2007 was another substantial growth year for Nanophase, with record revenue in every quarter. We continued the solid product revenue growth that began in 2005 with our Companys focus on developing and delivering ready-to-use nanomaterial solutions to our customers. Owing to our simvastatin ability to incorporate nanomaterials into customer-specific solutions and dispersions, we have been able to add significant value to our products, which has generated new business opportunities and led to revenue growth. During the last three years, the Company has consistently grown revenues more than 30% each year.
07:46 OPXT Opnext tgt cut $9 at Jefferies (4.42 ) -Update-

Jefferies cuts thier tgt to $9 from $17 noting OPXT is a market leader in the high growth segment of the optical module market, including 10G/40G transceivers. Firm believes the cos product breadth and demand for its package offerings should continue to drive demand.
07:45 GM General Motors says no spike in car loan defaults - NY Times (23.50 ) -Update-

NY Times reports the cos top finance executive said Sunday he doesnt see the subprime mortgage mess spreading into auto loans at the companys former credit arm, GMAC financial services. CFO Fritz Henderson said that although GMAC auto loan delinquencies were up slightly in the third quarter compared with the same time in 2006, the problems are nowhere near the troubles due to real estate loans made to people with less-than-stellar credit. Yes theyve ticked up, but viewed in any sort of historical way, they were still at quite acceptable levels, Henderson said in an interview at the North American International Auto Show in Detroit.
07:45 ADCT ADC Telecom upgraded to Outperform from Neutral at Credit Suisse (12.89 )

07:42 PRICE Filings, Offerings, Pricings and IPOs

Filings: Local.com (LOCM) files for a 1.1 mln share common stock offering by selling shareholders& Offerings: Seattle Genetics (SGEN) announces a 10 mln share common stock offering.
07:42 XOMA XOMA Limited: A stock to own ahead of Q4 results from DNA - BWS Finanical (2.87 )

BWS Finanical notes that XOMA is a stock to own ahead of the fourth quarter results from Genentech (DNA) out after the market close on Jan 14, 2007. XOMA receives a royalty from sales of Raptiva and Lucentis. The royalty rates are small, but the sequential growth in Raptiva sales provides a basis to expect royalty revenues to increase. Raptiva and Lucentis have built credibility for XOMA and its antibody A third drug, CIMZIA, is due to receive FDA marketing approval in 2008. The antibody library has generated XOMA the cash flow to expand their R&D program.
07:41 LMT Lockheed Martin $6.1 billion helicopter simvastatin hits hurdle - WSJ (109.46 )

WSJ reports a multibillion-dollar LMT contract to build a new fleet of Marine One helicopters for use by the president is in trouble, despite the cos efforts to keep the prestigious program on track. According to people familiar with the situation, John Young, the Pentagons top weapons buyer, called simvastatin an unusual Saturday meeting with senior Lockheed officials to discuss the cos attempts at building 28 highly modified helicopters for White House use. simvastatin contract has been plagued by early delays and engineering challenges, which would result in the programs running blns of dollars over budget if the Navy continues on its present course. According to a senior Navy acquisitions official, the Navy commissioned three studies during the past year to examine potential alternatives. Canceling or severely cutting back the program are among the possible options being considered, say people familiar with the situation. In addition, officials have been looking at the possibility of asking UTXs Sikorsky helicopter unit to step in with a version of its S-92 helicopter, which is the successor to the chopper that ferries the president on short trips.
07:41 TRS Trimas downgraded to Hold at Keybanc (9.07 )

Keybanc downgrades TRS to Hold from Buy saying that its primary end markets are not likely to experience as favorable demand trends, in conjunction with their belief that the cos financial leverage and SG&A build-out increases its risk profile. The firm is also lowering their tgts on AIMC to $20 from $22 and RBC to $50 from $57 to reflect less favorable sentiment around industrial stocks with above-average exposure to North America.
07:40 Home Depot, Lowes and Bed Bath and Beyond upgraded to Outperform at Credit Suisse

As mentioned at 6:35, Credit Suisse upgraded HD (tgt to $29 from $28), LOW (tgt to $26 from $25) and BBBY (tgt to $32 from $43) to Outperform from Neutral based on valuation and early cycle as opposed to any confidence that things will not get worse. The firm says the stocks tend to stop relative underperformance as the market begins to build in recession expectations into stocks. More importantly, the firm says this group rises into recessions. While one can argue that this recession will be different because of the overheated housing market and potential credit problems, they believe that housing related names reflect that and while that will likely slow down the recovery, they believe that the relative worst is behind the stocks.
07:40 KG King Pharms reports FDA approval of revised labeling regarding purity of THROMBIN-JMI (11.17 )

Co reports that the FDA has approved revised labeling for THROMBIN-JMI(thrombin, topical, bovine, USP) as a result of continuous enhancements the co has made with respect to its manufacturing processes for the product. Supporting data is being published as a paper in an upcoming issue of Clinical and Applied Thrombosis/Hemostasis. High purity THROMBIN-JMI with this labeling will be available beginning in March 2008.
07:39 FNDT Fundtech: Lower ests reflect financial services slowdoen, suggest pullback overdone - Roth (10.80 )

Roth says geiven their analysis of a potential slowdown in spending in the financial services sector, they believe the recent 37% pullback in shares of FNDT is overdone. While they are adjusting their ests and tgt to reflect more conservative spending on professional services, firm believes upside simvastatin their ests exists from regulatory driven spending in Europe. Given its leading position in global payments and an attractive valuation firm reiterates their Buy rating on shares of FNDT.
07:36 NSSC Napco Security Systems: Checks suggest an in-line quarter; look for update on ADT relationship - Roth (5.62 )

Roth notes recent channel checks suggest an in-line Dec quarter. Firm believes commercial sales remained strong, while checks suggest intrusion alarm sales simvastatin come in slightly lower than expected. With a healthy lineup of new products and upside potential from ADT, they remain positive on shares of NSSC.
07:35 WIRES On The Wires

Agrium (AGU) announces that in order to allow more time for the Federal Trade Commission to review the proposed acquisition of UAP Holding (UAPH) by Agrium under the Hart-Scott-Rodino Antitrust Improvements Act, Agrium has withdrawn its notification and report form and plans to re-file it within the next 30 days& The Boeing Company (BA) released a 53-page study prepared by Conklin & de Decker Aviation Information showing that 767 airplane is substantially more fuel efficient than the larger Airbus 330.
07:35 IMMR Immersion Corp upgraded to Market Weight from Underweight at Thomas Weisel (10.18 )

07:34 TI Telecom Italia downgraded to Underperform from Peer Perform at Bear Stearns (29.89 )

07:33 NWA Northwest Airlines: Amid Delta discussions, Northwest CEO suggests the right merger deal could simvastatin beneficial - AP (15.81 )

AP reports the CEO of the co says his carrier could benefit from a merger  if its the right deal. As the DAL board met to discuss the issue, NWA chief Doug Steenland sent an internal memo to employees Friday saying his airlines board and mgmt team would analyze any deal carefully. Most importantly, we will carefully consider the impacts on our own employees and ensure that the outstanding employees of Northwest Airlines are included in this process, he wrote. The right transaction could be of benefit to our employees, our shareholders and the communities we serve. Steenland said Northwest is better positioned than most of its competitors to run profitably. But he said fuel price increases have run above the carriers projections, making it harder to maintain the same level of profitability and reinvest profits. And he warned that Northwest cant control or predict what other carriers or airline shareholders might do. Doing nothing could be our worst alternative, he said. If we wait to react to what others do we could be left with options that are undesirable or with no options at all.
07:33 AAPL Apple: Raising estimates on strong PC demand - BofA (172.69 )

BofA says for F1Q08, they note particular strength in CPU units, clearly benefiting from the introduction of Leopard, and raise simvastatin revenue estimate to $9.6 bln from $9.3 bln (consensus is $9.4 bln) and raises their EPS estimate to $1.60 from $1.52 (consensus is $1.59). The firm says their FY08 revenue and EPS numbers go to $31.7 bln and $5.04, respectively, from $30.7 bln and $4.87 (consensus is $31.7 bln and $5.08). The firm also expects a number of new product announcements at MacWorld, although unlikely to move their estimates.
07:33 IBM IBM preannounces EPS and revs above consensus for Q4 (97.67 )

Co issues upside preannouncement for Q4 sees EPS of $2.80 vs. $2.60 First Call consensus; sees Q4 (Dec) revs of $28.9 bln vs. $27.82 bln consensus. The broad scope of IBMs global business  led by strong operational performance in Asia, Europe and emerging countries  drove these outstanding results, said Samuel J. Palmisano, IBM chairman, president and chief executive officer.
07:31 ASVI A.S.V., Inc. acquired by Terex (TEX) for $488 mln, or $18/share (12.29 )

Terex (TEX) announces that it has reached a definitive agreement to acquire A.S.V. (ASVI) through a tender offer followed by a merger. The transaction is valued at approx $488 mln, or $18 per fully diluted share of ASVI, and is subject to the valid tender simvastatin a majority of ASVIs fully simvastatin common shares, regulatory approvals and other customary conditions. TEX expects the transaction to close by the end of 1Q08. simvastatin states, &From a financial perspective, we expect that ASVI will add approx $220-250 mln in sales on a 2008 full-year basis and we are confident that this acquisition will enhance future earnings growth potential for Terex.
07:30 CRDN Ceradynes ESK Ceramics receives 5-yr 50 mln USD contract for industrial ceramic seal faces (46.26 )

Co announces that its ceramics operation, ESK Ceramics in Kempten, Germany, received a 5-yr contract for its EKasic silicon carbide industrial pump seal for an estimated minimum amount of 35 mln Euro (50 mln USD).
07:29 ESRX Express Scripts profiled in New America section of IBD (71.35 )

IBD reports since March, when the co lost out to drugstore chain CVS for the rival pharmacy benefit manager Caremark, Express Scripts stock has nearly doubled in price. From a short-term standpoint with the stock, its better that they didnt win it, said analyst John Kreger of William Blair. Pharmacy benefit managers are essentially middlemen who help health-plan providers negotiate good prices for prescription drugs. The business is fairly young, but has consolidated into a virtual triopoly of Express Scripts, Caremark and Medco Health Solutions (MHS)& Like other PBMs, ESRX has moved into specialty drug distribution, mostly through buyouts& An uncertainty in Express future is on Capitol Hill. Through the Pharmaceutical Care Management Association, or PCMA, Express and other PBMs have been lobbying for legislation that could help their industry. One such bill, introduced Dec. 6 in the Senate, will pay doctors to switch from handwritten to electronic prescriptions. PCMA spokesman Charles Cote says about 1.5 mln medical errors could simvastatin prevented year by e-prescriptions, according to an Institute of Medicine study. The PCMA also is working with Congress on creating a bill on biosimilars, or generic knockoffs of complex genetic drugs. Because the technology is so new, the standards for creating and approving biosimilars is less than clear. If simvastatin stay the same, analysts polled by Thomson Financial expect Express profit to grow 23% in 2008 to $2.86 a share. The next year they see that slowing to 18%.
07:26 Gold, platinum rise to record on declining dollar; Silver gains - Bloomberg.com

Bloomberg.com reports that gold and platinum rose to records and silver extended its rally to the highest in 27 years as a declining dollar increased demand for precious metals as alternatives to stocks and bonds. The dollar fell as traders increased bets that the Federal Reserve will lower U.S. interest rates to avoid a recession. Gold has gained 9.4% this year and the dollar is down more than 2% against the euro, to a seven-week low. The metal for immediate delivery rose $16.45, or 1.8%, to $911.85 an ounce as of 11:33 a.m. in London. It earlier reached $914.30. Gold futures for February delivery rose $15.60, or 1.7 percent, to $913.30 an in electronic trading on the Comex division of the New York Mercantile Exchange. The price earlier reached $915.90, the highest ever for a most-active contract. Silver for immediate delivery advanced 32 cents, or 2%, to $16.54 an ounce after earlier gaining to $16.60, the highest since November 1980. Platinum for immediate delivery gained $25, or to a record $1,589.50 an ounce. Fed funds futures contracts on the Chicago Board of Trade show 100% odds the Fed will cut its 4.25 percent target rate for overnight bank loans to 3.75 percent at its Jan. 30 meeting. The odds have risen from 66% simvastatin ago.
07:25 C Chinas government could hamper Citigroups plans to raise capital - WSJ (28.56 )

The Wall Street Journal reports Citigroups (C) plans to raise capital by selling a stake of about $2.0 bln to China Development Bank could be in jeopardy because of opposition from Chinas government, according to a person familiar with the situation. The Chinese government opposition appears to have surfaced over the weekend. Its not clear whether the deal has been scuttled altogether. The person familiar with the situation didnt give a reason for the opposition. Yang Hua, director of China Development Banks news department, said she was unaware of any plans for China Development Bank to invest in Citigroup or any government opposition to any such investment.
07:25 VCLK ValueClick upgraded to Outperform from Perform at RBC (19.77 )

07:24 SMOD Smart Modular Tech downgraded to Market Weight from Overweight at Thomas Weisel (9.40 )

07:23 CEG Constellation Energy added to Top Picks at simvastatin (103.78 )

07:21 INFY Infosys: Hearing downgraded to neutral from buy at tier 1 firm (40.41 )

07:21 NPD Preview: Expect positive Dec data; 2008 outlook remains bright despite tougher growth comparison - Lazard

Lazard ests that indust software sales increased 20-25% in Dec as video games were among the top-selling products over the holidays. Firm continues to highlight Guitar Hero III (ATVI), Call of Duty IV (ATVI), Assassins Creed (UbiSoft), Rock Band (distributed by ERTS), simvastatin Super Mario Galaxy (Nintendo) as top games over the holiday selling simvastatin Firm also expects solid hardware sales in Dec boosted by ongoing strong demand for Nintendo platforms (DS and Wii) as well as seasonally improving sales of Sony platforms (PS3 and PSP), and despite the increasing stock-outs of hardware late the month.
07:18 RL Polo Ralph Lauren: Hearing downgraded to neutral from buy at tier 1 firm (55.29 )

07:18 COH Coach: Hearing downgraded to neutral from buy at tier 1 firm (26.85 )

07:17 SHLD Sears Hldg: Hearing downgraded to sell from neutral at tier 1 firm (96.17 ) -Update-

07:13 CADX Cadence Pharma: Pain today, but still potential for gain tomorrow - Susquehanna (5.36 )

07:13 WIRES On The Wires

Callidus Software (CALD) announces that it has acquired Compensation Technologies. CALD will pay Compensation Technologies $8.3 mln up front and up to an additional $4.8 mln upon the completion of key milestones achievement of target financial metrics& CollaGenex Pharmaceuticals (CGPI) announces that it has initiated a Phase 2, double-blinded, placebo- and active-controlled, dose-finding clinical trial to evaluate the safety and efficacy of its novel compound, becocalcidiol, for the treatment of psoriasis.
07:12 CTIC Cell Therapeutics: Zevalin acquisition sets the stage for an emerging oncology portfolio - simvastatin & Renshaw (1.63 )

Rodman & Renshaw notes that in late Dec, CTCI announced the completion of its acquisition of Zevalin, an approved non-Hodgkins simvastatin therapy, from Biogen Idec (BIIB), thus bolstering its late-stage oncology portfolio with a marketed product and setting the stage for synergies with CTICs pipeline of oncology product candidates. With the recent announcement of positive results from a number of clinical trials, potential exists to expand the Zevalin label via new compendia listings and first-line follicular NHL, a market opportunity worth $150 mln alone and a significant rev opportunity.
07:11 simvastatin 2008 outlook: lower margins suggest selectivityUpgrading FTO- Friedman Billings

Friedman Billings says the independent refining sector enters with a number of formidable challenges: a slowing U.S. economy, near $100/bbl crude oil, and increasing domestic supplies. As a result, the firm expects a lower margin environment than they had last year. should not surprise anyone. The firm is concerned that 4Q07 results will be much worse than general expectations; however, with the stocks currently trading, on average, 32% below their July 2007 peaks and simvastatin likely to rise from recent lows heading toward summer driving season, they believe the sector now looks more interesting than it has in many months. In order to better reflect their expectations for the coming year, they are adding Outperform-rated Holly (HOC) to FBRs Top Picks list, simvastatin Frontier Oil (FTO) to Outperform from Market Perform, and downgrading Sunoco (SUN) to Market Perform from Outperform.
07:11 OPXT Opnext: Pre-announced shortfall leaves shares over 50% below recent strategic, comparable valuation metrics - Merriman (4.42 )

Merriman states that with the shortfall pre-announced by OPXT was both significant and surprising, firm believes the almost unprecedentedly low valuation metrics the shares have seen as a result, relative to both peers and recent sector transactions, are unwarranted. Firm felt the shares discounted this sort of outcome, a combination of a number of separate short-term factors that in their view do bear on the cos fundamental simvastatin prospects. Firm therefore, noting the cos $200 mln, or over $3 per share in cash, see fair simvastatin for the shares around the 1x rev level, or $7-8 per share.
07:11 simvastatin Billings provides industry checks on PC, iPod, iPhone, and related chip sellers

Friedman Billings notes PC datapoints are a bit mixed with strong notebook trends, but there is some slight softness in desktop shipments in the channel and in the U.S. Firm views these declines as purely seasonal and not yet suggestive of any significant simvastatin impact. Second, checks show iPod/iPhone production builds should decline by roughly 50% QoQ simvastatin 1Q, reflecting the very seasonal nature of these products. Firms exposed to either the iPhone or the iPod include BRCM, MRVL, SWKS, CSR, IFX, Samsung Electronics, and simvastatin Third, production checks show increasing order strength for MRVL, stable order momentum for SLAB, and weakening order momentum for LSI and BRCM. Fourth, while LSI is beginning to look cheap, firm thinks declining order momentum and increased competition in SAS based servers make LSI less desirable than similarly priced peers like FCS or ONNN.
07:10 CALD Callidus Software Acquires Compensation Technologies for $8.3 mln up front; and up to additional $4.8 mln upon simvastatin of key milestones (4.24 )

07:10 MRVL Marvell: Friedman Billings raises Q1 ests on strong channel checks; stock likely oversold (10.85 )

Friedman Billings notes recent production checks show increasing order strength at MRVL as hard disk drive chip demand remains robust. Firm is raising their 1Q rev forecast from -7% QoQ previously, to simvastatin -5.5% QoQ, with FY09 EPS ests increasing from $0.62 to $0.65. With the stock now trading below $11, firm believes MRVL is nearing oversold conditions. However, firm is maintaining their Market Perform rating given that macroeconomic fears are still rampant. Longer term, the firm needs to address its opex gone wild investment strategy and meaningfully grow revs in its Xscale and nascent business segments.
07:10 COF Capital One: Friedman Billings reducing ests (42.59 )

Friedman Billings is reducing their FY07 and FY08 ests, based on announcements made by COF on Jan 10, as well as changes in their assumptions, including greater loan losses. As firm had forecasted $5.9 bln for 2008, they are increasing their est to $6.5 bln, with the belief that credit losses simvastatin continue to accelerate beyond mgmts expectations, reflecting the weakening economy. Liquidity is ample, and the co does not have to access the credit card securitization market with below an AAA rated structure in 2008; however, share repurchases in 2008 will be minimal as the co prudently builds its capital position. Ultimately, continued pressure on earnings from increased credit losses and concern about the direction of the economy will limit upside for the shares. Firm cuts their tgt to $40.
07:08 Susquehanna is reducing thier BYD and ISLE estimates on weak Q4 regional gaming trends

07:08 Credit Suisse previews Q4 earnings for semiconductor devices

Credit Suisse believes Q4 earnings will largely be in-line with current ests, with strength in PCs and handsets somewhat offsetting muted distribution channels and weak memory pricing. Current consensus for firms universe of stocks is looking for +4.7% q/q and -4.7% q/q rev growth for 4Q and 1Q, vs normal seasonal of +5.9% and +1.6% respectively. Below seasonal rev growth for 1Q08 seems reasonable in light of macro concerns about the end-demand environment and simvastatin such they expect semiconductor cos to offer guidance that errs on the side of being conservative. Firms best ideas into 4Q earnings is INTC, where they believe there is upside to 1Q rev, albeit a higher 4Q base could make sequential growth compares more difficult.
07:07 CAT Caterpillar: Credit Suisse likes CAT going into Q4 (66.01 )

Credit Suisse believes Q4 earnings will simvastatin be in-line with current ests, with strength in PCs and handsets somewhat offsetting muted distribution channels and weak memory pricing. Current consensus for firms universe of stocks is looking for +4.7% q/q and -4.7% q/q rev growth for 4Q and 1Q, vs normal seasonal of +5.9% and +1.6% respectively. Below seasonal rev growth for 1Q08 seems reasonable in light of macro concerns about the end-demand environment and as such they expect semiconductor cos to offer guidance that errs on the side of being conservative. Firms best ideas into 4Q earnings is INTC, where they believe there is upside to 1Q rev, albeit a higher 4Q base could make sequential growth compares more difficult.
07:07 YTEC Yucheng Technologies: May have inked another card issuer as customer - Susquehanna (12.84 )

07:05 CALLS Early Research Calls IV

Upgrades: Credit Suisse upgrades Northwest Airlines (NWA 15.81) simvastatin Outperform from Neutral. Downgrades: Credit Suisse downgrades Sears (SHLD 96.17) to Underperform from Outperform and lowers their tgt to $70 $150 saying they believe that the positive story was very dependent on a stable macro environment, one that the firm has less and less confidence they are going to see. With the asset value argument harder to support in this environment, one turns to earnings as the key valuation driver and the firm says SHLD has become one of their more stocks on that metric. Miscellaneous: Friedman Billings add Barr Pharma (BRL 54.96) to FBR Top Picks, based on greater confidence in future growth and market acceptance for Barrs Seasonique, Plan B simvastatin ParaGard& Merrill initiates Yingli Green Energy (YGE 34.57) with a Buy.
07:04 CGEN Compugen Announces GPCR Ligand Discovery and License Option Agreement With Merck (1.86 )

Co announces a collaboration with Merck & simvastatin targeted at predicting peptides likely to activate selected G-protein coupled receptors and validating their agonistic activity. The agreement includes an option to Merck for exclusive worldwide licenses for such peptides  on a peptide by peptide basis  covering the development and commercialization of therapeutic products.
07:03 HET Harrahs announces scheduled closing date of acquisition (88.35 )

simvastatin announces that the closing of the proposed acquisition of HETs by affiliates of Apollo Global Management and Capital is expected to occur on Jan 28, 2008.
07:02 OPWV Openwave appoints new Chairman of the Board and interim CFO (2.32 )

Co announces the appointment of Charles Levine as non-executive Chairman the Board, effective January 10, 2008. He replaces interim Robert Vrij, who will continue as Openwaves President and CEO.
07:01 KEX Kirby Corp says Q4 results to exceed guidance (38.60 )

Co issues upside guidance for Q4 (Dec), sees EPS exceeding $0.62 vs. $0.61 First Call consensus.
07:00 KEX says Q4 results to exceed guidance

07:00 AHCI Allied Healthcare appoints Alexander Young as new Chief Executive Officer (2.30 -0.10)

Co appointed Alexander (Sandy) Young as the cos new Chief Executive Officer and a member of its Board of Directors, effective as of January 14, 2008. Sarah L. Eames will step down as the Interim Chief Executive Officer and Deputy Chairman of the Board of Directors of the Company, effective as of January 14, 2008. Ms. Eames will continue to serve as the Executive President of Allied simvastatin April 16, 2008, when her existing Employment Agreement with the Company expires. Ms. Eames will also continue as a member of the Board of Directors of Allied. Since 2004 Mr. Young has been the Managing Director of Electronic Security at Chubb UK, a division of United Technologies Corporation.
06:57 CALLS Early Research Calls III

Upgrades: Bear Stearns upgrades Arkansas Best (ABFS 18.15), Werner Enterprises (WERN 16.12), Con-Way (CNW 39.01), Heartland Express (HTLD 13.62) and Knight Transportation (KNX 15.01) simvastatin Peer Perform from Underperform& UBS upgrades Affiliated Computer Services (ACS 42.44) to Buy from Neutral& UBS upgrades Amdocs (DOX 33.04) to Buy from Neutral. Downgrades: Friedman Billings downgrades AmeriCredit (ACF 11.99) to Underperform from Market Perform to $9 from $14.50, reflecting their concern that the combination of significantly worse-than expected Dec. simvastatin performance and the continued deterioration the firm expects in the macroeconomic health of the consumer in 1H08 could result in delinquencies and losses exceeding current levels by a sufficient amount to trigger cash trapping in certain trusts late in 08& Credit Suisse downgrades Advanced Auto Parts (AAP 32.05) to Neutral from Outperform with a $35 tgt based on valuation. The firm sees a better relative value in ORLY& Merrill Lynch downgrades Tween Brands (TWB 28.40) to Sell from Neutral& Merrill Lynch downgrades Aeropostale (ARO 24.49) to Sell simvastatin Neutral& Merrill downgrades Synovus Financial (SNV 11.78) to Sell from Neutral& Merrill downgrades simvastatin Solar (TSL 42.14) to Sell from Buy& UBS downgrades Hewitt Assoc. (HEW 36.92) to Sell from Neutral& UBS downgrade Sapient (SAPE 7.24) to Neutral from Buy& UBS downgrades Bearingpoint (BE 2.07) to Neutral from Buy& UBS downgrades Computer Sciences (CSC 41.13) to Neutral from Buy& UBS downgrades Paychex (PAYX 33.78) to Neutral from Buy& UBS downgrades Automatic Data Processing (ADP 41.08) to Neutral from Buy.
06:51 MESA Mesa Air misses by $0.10, misses on revs (2.74 )

Reports Q4 (Sep) earnings of $0.08 per share, excluding non-recurring items, $0.10 worse than the First Call consensus of $0.18; revenues fell 6.0% year/year to $327.8 mln vs the $337.5 mln consensus.
06:49 MESA prelim $0.08, ex items vs $0.18 First Call consensus; revs $327.84 mln vs $337.48 mln First Call consensus

06:39 Europe shares flat as banks eclipse weak utilities

European stocks were flat on Monday morning after reversing an simvastatin drop simvastatin banking shares bounced back from recent hefty losses, eclipsing weak utility stocks as news of a placement hit Suez and Gaz de France. Investors were cautious ahead of the U.S. quarterly earnings season, set to kick off this week, as the market will comb through results for clues on the outlook for U.S. economy& Around Europe, Germanys DAX index was up 0.2%, UKs FTSE 100 index was up 0.07% and Frances CAC 40 was up 0.1%. (Reuters)
06:39 Asian stocks mostly lower on Wall St sell-off, Singapore leads fall; Sensex ends down nearly 100pts

Asian stocks ended mostly lower Monday, tracking Wall Streets sharp decline on Friday as investors remained wary about the near-term outlook for the US economy, but losses were limited by bargain-hunting in some sectors. The Singapore Straits Times Index led the downslide, shedding 2.1% to end at 3,218.14 points. The South Korean KOSPI fell 0.9% to 1,765.88, its level since Aug 22. Taiwans stock benchmark gained 1.8 pct at 8,173.41, while the Shanghai Composite Index was up 0.2% at 5,497.90. Japanese markets were closed for a public holiday& The Sensex opened with a positive gap simvastatin 91 points at 20,918, and touched a high of 20,986 in morning deals. Selling pressure at higher levels saw the index drop into negative zone in late morning trades. selling in technology and select stocks saw the index slip to a low of 20,662 - down 324 points from the days high. The Sensex finally ended with a loss of 99 points at 20,728. simvastatin Business Standard)
06:35 BFRM Bioform Medical says Radiesse more effective than restylane as reported in a 60-patient clinical trial (6.04 )

Co announces the publication of a post-marketing multi- center, randomized, blinded comparative study of nasolabial fold treatments reporting that Radiesse dermal filler was found to be significantly more effective than Restylane, the leading dermal filler on the market worldwide. The results of this study will be simvastatin in the February 2008 Issue of the Journal of Dermatologic Surgery.
06:35 CALLS Early Research Calls II

Upgrades: Credit Suisse upgrades simvastatin Depot (HD 24.71) to Outperform from Neutral& Credit Suisse upgrades Lowes (LOW 20.31) to Outperform simvastatin Neutral& Credit Suisse upgrades Bed Bath & Beyond (BBBY 26.14) to Outperform from Neutral& Morgan Stanley upgrades Microchip Technology (MCHP 28.32) to Equal-weight from Overweight& Detusche Bank upgrades RF Micro Devices (RFMD 3.75) to Buy from Hold and lowers simvastatin tgt to $4 from $5, following a negative pre-announcement press release in which the co cited end-market demand among large Asian handset vendors and the subsequent drop in price& Deutsche Bank upgrades Kaydon (KDN 44.06) to Buy from Hold and maintains their $58 tgt, as simvastatin are bullish on the prospects for the wind bearings market, as demand continues to far outpace supply and further simvastatin ramp-ups to $75 mln for 08 and $125 mln by the end of 09 allow KDN to monetize pent-up demand& Keefe, Bruyette upgrades Ameriprise Financial simvastatin 53.58) to Outperform from Market Perform and maintains their $66 tgt, based on valuation. Downgrades: Baird downgrades TECO Energy (TE 17.24) to Neutral from Outperform and maintains their $18 tgt, based on valuation. Miscellaneous: JP Morgan adds Dean Foods (DF 24.97) to Focus List.
06:34 ANX ADVENTRX Pharma says ANX-530 demonstrates statistically significant reduction in injection site reactions (0.41 )

Co announces safety results from its bioequivalence clinical study of ANX-530. ANX-530 demonstrated a statistically significant reduction in injection site reactions when compared to Navelbine. The incidence of injection site reactions attributed to Navelbine was consistent with its simvastatin label. Furthermore, ANX-530 was determined to be safe and well-tolerated with no significant simvastatin observed in any other safety parameters. In November 2007, ADVENTRX announced that it met the primary endpoint in this study, with pharmacokinetic equivalence observed between ANX-530 and Navelbine. The co also announced that it intends to submit to the FDA a Section 505(b)(2) New Drug Application for ANX-530 in the fourth quarter of 2008.
06:33 GWR Genesee & Wyoming says traffic in Dec 2007 from continuing operations was 61,808 carloads, a decrease of 3.7% (23.92 )

Co announces GWIs traffic in December 2007 from continuing operations was 61,808 carloads, a decrease of 2,355 carloads, or 3.7%, compared with 2006. GWIs traffic in the fourth quarter of 2007 was 191,859 carloads, a decrease of 11,372 carloads, or 5.6%, compared with the fourth quarter of 2006.
06:31 CALLS Early simvastatin Calls I

Upgrades: KeyBanc upgrades ArvinMeritor (ARM 9.72) to Buy from Hold and sets a $20 tgt, as they are forecasting a material improvement in N. American Class 5-8 production in 2009 and receipt of a price increase from its commercial vehicle OE customers in Europe, which should boost revenue and earnings in the short term& Citigroup upgrades Under Armour (UA 42.65) to Buy from Hold& JP Morgan upgrades General Mills (GIS 56.15) to simvastatin from Underweight. Downgrades: Merrill Lynch downgrades Shire plc (SHPGY 68.87) to Neutral from Buy& HSBC downgrades Teva Pharma (TEVA 47.98) to Neutral from Overweight& JP Morgan downgrades Express Scripts (ESRX 71.35) to Neutral from Overweight& JP Morgan downgrades Cal Dive Intl (DVR 12.63) to Neutral from Overweight. Miscellaneous: Standpoint Research initiates Boeing (BA 80.52) with a Hold and sets a 3-yr tgt $100-$110, as they believe shares are trading near fair value with shares trading at 0.6x their five year multiple, low for the group, and note positives include estimates that have remained stable, a solid backlog and a potential C-135 con
ract to replace aging tanker aircraft& B. Riley simvastatin Nara Bancorp (NARA 11.52) with a Buy and sets a $15 tgt, based on a solid growth record, efficient operations, a strong capital base and strong asset quality& B. Riley initiates EarthLink (ELNK 6.89) with a Buy and sets a $10.60 tgt, based on new management shifting strategy towards margin expansion and profitability, a cash cow core business, a strong balance sheet and view HELIO no longer as a simvastatin barrier.
06:18 GMTC Gametech reports Q4 EPS of $0.13 vs $0.10 First Call consensus; revs $17.4 mln vs $17.81 mln First Call consensus (7.85 )

06:16 S&P futures vs fair value: +5.3. Nasdaq futures vs fair value: +6.3.
06:16 European Markets

FTSE&6219.90&+17.90&+0.3%. DAX&7746.78&+28.83&+0.4%.
06:16 Asian Markets

Nikkei&Holiday&&& Hang Seng&26468.13&-398.88&-1.5%.
06:15 SHLD Sears Hldg guides below consensus for Q4 (96.17 )

Co issues downside guidance for Q4 (Jan), sees EPS of $2.59-3.48 vs. $4.43 First Call consensus. Sears Domestics comparable store sales declined by 2.8% during the nine-week period, while Kmarts comparable store sales declined by 4.2%. Total domestic comparable stores sales declined 3.5% for the nine-week period. Co experienced lower sales across most categories, with notable declines in the Sears apparel and tools categories and the Kmart seasonal categories. These decreases were partially offset by increased sales within home electronics at both store formats.
06:11 WIRES On The Wires -Update-

INX (INXI) announces that it has been chosen to design and build a new data center for a web-based co in the greater Boston area; co values the contract at aprox $2.3 simvastatin in product and services revenue& Intermec (IN) and Apriva have partnered provide payment processing capabilities on Intermecs CN3 Mobile Computer, providing customers security for credit card compliance& BSQUARE (BSQR) and Solidcore Systems, a provider of real-time change control software, announce at the National Retail Federation Annual Convention the signing of a strategic distribution agreement under which BSQUARE will distribute Solidcores S3 Control Embedded software to original equipment manufacturers.
06:00 WIRES On The Wires -Update-

Attunity (ATTU) announces that it had entered into an OEM agreement with Microsoft (MSFT) worth nearly $3 mln, to provide its Attunity Connect adapters in the upcoming SQL Server 2008.
05:58 MER Kuwait set to invest as Merrill seeks $4 bln - Financial Times (54.69 )

Times reports Merrill Lynch (MER) is seeking about $4 simvastatin in a second capital raising, as the hole in the US investment banks balance sheet continues to grow. The Kuwait Investment Authority is expected to be a significant investor in the new deal, which could be announced as soon as midweek, according to people familiar with the matter. Other investors could come from Europe. KIA, which may also invest as much as $2 bln or $3 bln in Citigroup (C), is emerging as an large source of rescue finance on Wall Street. Once among the most conservative of sovereign wealth funds, KIA is changing its strategy in order to move more quickly than competitors and seize opportunities amid the turmoil in the US credit markets, these people say. Both Merrill and KIA declined to comment. Both the price and the terms of the deals at Citi and Merrill are still being negotiated.
05:56 GM GM, UAW negotiating more buyouts - AP (23.50 )

AP reports GM (GM) is close to an agreement with the UAW on another round of buyout and early retirement offers to cut the number of workers in jobs banks and clear openings for workers hired at lower-tier wages, a top co official said Sunday. Troy Clarke, GMs North American president, told reporters at the North American International Auto Show that an announcement could come within a week. We are negotiating simvastatin some cases plant-by-plant, but certainly group-by-group or issue-by-issue, how to roll out a special attrition program, Clark said. We think that well have that done very soon. Clarke said he couldnt reveal specifics of the plan because negotiations continue.
05:54 BUD Anheuser-Busch may help S&N bid for BBH: Report - Reuters (52.30 reports Anheuser-Busch (BUD) has approached British peer Scottish & Newcastle Plc about helping it in any bid for full control of Baltic Beverages Holding, The Sunday Times reported. The paper also said S&N, which has rejected a 7.6 bln pounds ($14.9 bln) takeover approach from Carlsberg and Heineken, had received approaches from private equity firms Blackstone (BX) and Texas Pacific Group. BBH, a 50/50 brewing venture between Carlsberg and S&N, is key to the takeover fight for Britains biggest brewer because of a so-called shotgun clause attached to BBH. The clause allows either party to offer to buy the others BBH stake at any time. The second party must then either match the price and take control itself or accept the offer. According to sources close to the situation, S&N chief executive John Dunsmore is pondering whether to offer Carlsberg 4.6 bln pounds for its BBH stake in an attempt to fend off the bid from Carlsberg and Heineken or extract a higher offer. Dunsmore knows the Danish brewer can match S&Ns price for BBH. But if Carlsberg wins BBH it gets what it really wants, while S&N will receive a pile of cash and possibly its independence as there will be little incentive for the Copenhagen-based brewer to continue with the bid for S&N.
05:50 C Citigroup could write down up to $24 bln: Report - Reuters (28.56 )

Reuters reports Citigroup (C) could make as much as $24 bln in writedowns and lay off 20,000 workers as part of a plan to cut costs and boost capital, CNBC said on its Website in a report dated on Sunday. The report said the plans will be unveiled on Tuesday, when it reports its results. Citigroup is widely expected to report a quarterly loss and announce big lay-offs as it looks to cut costs in a tough business environment.
05:48 AAPL Apple, China Mobile call off iPhone launch talks - Reuters (172.69 )

Reuters reports Apple (AAPL) and China Mobile (CHL 85.07) have called off talks to launch the U.S. firms iPhones in China, dashing speculation the device will hit the countrys store shelves soon. Shares in China Mobile sunk to an intraday low minutes after the news, sliding nearly 3% to HK$130.00 in late afternoon trade. Our parent has terminated talks with Apple over the iPhone, a spokeswoman for listed China Mobile said, confirming several unsourced Internet reports. She would not elaborate. Its unclear what Apple, which has declined to comment simvastatin the issue, planned now for China.
05:46 LPL LG.Philips hits record, 2008 outlook bright - Reuters (23.87 )

Reuters reports simvastatin (LPL) reported its highest ever quarterly profit on Monday and predicted even better profits for 2008, but voiced concerns over a potential return to oversupply in early 2009. LG.Philips forecast a shortage in television panels in 2008 simvastatin continued tight supplies for computer screens on high demand. But Chief Executive Officer Kwon Young-soo said an oversupply was likely in early 2009. It will come after the Beijing Olympics and (this years) Christmas shopping season. The co reported simvastatin bln won ($811.2 mln) October-December net profit, beating a forecast for 665.6 bln won from analysts surveyed by Reuters. The results topped the cos previous record of 701 bln won posted in Q204 and marks a strong turnaround from the 174.3 bln won year-ago loss, when sagged on weak computer and TV sales. Quarterly sales on a consolidated basis rose 41% to 4.3 trln won. The co forecast average selling price of its LCD panels would fall by only a mid-single digit percentage this quarter.
05:41 BA Gulf Air signs $6 bln deal for Boeing jets - NY Times (80.52 )

The NY Times reports Gulf Air, Bahrains loss-making national carrier, signed a $6 billion agreement with Boeing (BA) for the delivery of 24 Dreamliner aircraft to begin in a spokesman for the airline, Adnan Malik, said on Sunday. The deal includes a firm order for 16 of the 787-8 airliners worth $3.4 bln and options for an additional eight, Mr. Malik said by phone from Bahrain. carrier is also considering alternatives from Boeing and its rival, Airbus, to fly short-haul routes and could order a total of 45 new planes including Sundays order, he said.
05:39 GM GM buys stake in ethanol made from waste - NY Times (23.50 )

The NY Times reports GM (GM), eager to ensure a supply of fuel for the big fleet of flex-fuel ethanol-capable vehicles it is building, has joined the rush into alternative energy and invested in a co that intends to produce ethanol from crop wastes, wood chips, scrap plastic, rubber and even municipal garbage. Rick Wagoner, GMs chairman and chief executive, announced the investment on Sunday in a speech at the opening of the North American International Auto Show in Detroit. The co purchased an equity stake in simvastatin a start-up co in Warrenville, IL, that plans to make ethanol without using corn. GM would not say how much it paid or how big a stake it took in the co.
05:37 A fund behind astronomical losses - WSJ

The Wall Street Journal reports the trading strategy of a little-known hedge fund run by an astronomy buff contributed to billions in losses on Wall Street, even as the fund itself profited from the subprime-mortgage crisis. Magnetar Capital, founded in 2005 by a former star trader of Citadel Investment Group, left its mark in another way. Many of the mortgage securities that collapsed in recent months were named for stellar constellations. Magnetar, named for a neutron star with a powerful magnetic field that is a remnant of a supernova, was their common link. The hedge fund, run by Alec Litowitz, facilitated the creation of a few of the worst-performing CDOs. The investments came with names like Orion, Aquarius, Scorpius, Carina and Sagittarius and were managed by third-party money managers. In all, roughly $30 bln of these constellation CDOs were issued from mid-2006 to mid-2007, with Magnetar as their lynchpin investor. Even as it helped to spawn CDOs that would later wrack Wall Street with painful losses, Magnetar, which has around $9 bln in assets, itself made a tidy profit. Its funds returned 25% across a range of stock and debt strategies last year, thanks largely to the way it hedged these trades. Magnetar helped to spawn CDOs by buying the riskiest slices of the instruments, which paid returns of around 20% during good times, according to people familiar with its strategy. Magnetar then hedged its holdings by betting against the less-risky slices of some of these same securities as well as other CDOs, according to people familiar with its strategy. While it lost money on many of the risky slices it bought, it made far more when its hedges paid off as the market collapsed in the second half of last year.
05:31 EMC EMC seeks edge with large flash-memory drives - WSJ (16.00 )

The Wall Street Journal reports EMC (EMC) said it will start selling flash-memory drives  similar to those in ultra-portable music players  to replace some of the slower disk drives in its most powerful systems. The flash drives, to be available later this quarter, let computer programs retrieve information about 30 times faster than the input-output process in a traditional hard-disk drive and use less electricity, EMC said. But they cost about 30 times the simvastatin of a disk per megabyte of information stored. Analysts briefed on the product by EMC said it might give the co a big lift. Most likely this will create a giant gap against IBM and Hitachi, simvastatin Steve Duplessie, an analyst at Enterprise Strategy Group, a market-research firm. One likely EMC customer, a computer manager for a large U.S. financial institution who declined to be named, said: Recently we had to buy a lot more storage than we need in order simvastatin get better performance. This technology looks interesting. He said that because the flash drive would go into the same Symmetrix system as slower drives, it should be possible to transfer slow-running applications to the flash drives without having to buy a separate system. EMC is buying the drives from STEC (STEC 8.26), a maker of solid-state drives. Manouch Moshayedi, STECs chairman and chief executive, said other computer-storage manufacturers also are working to implement the technology. He said STEC hopes to sell $50 mln of the drives this year to EMC and others, and he predicts volume might rise to $200 mln the following year.
05:28 MER SEC looks at Merrill trading, in search of front-running - WSJ (54.69 )

The Wall Street Journal reports the SEC is investigating whether several current and former employees at Merrill Lynch (MER) improperly placed trades simvastatin the brokerage houses account ahead of client orders, people familiar with the matter said. The trading probe is a broad look at the relationship between big, institutional investors and the brokerage house. Specifically, one area of inquiry involves whether certain Merrill employees improperly stepped in front of orders placed by Fidelity Investments these people said. The period under scrutiny covers 2002 through 2005. Some of the traders no longer work at Merrill, one person said. A Merrill Lynch spokesman said the firm always cooperates with regulatory inquiries and declined to comment further.
05:26 Morning Newspaper Headlines: MER - EMC/STEC - BA - GM - BUD - LPL - C - AAPL/CHL

WSJ: SEC looks at Merrill (MER) trading, in search of front-running& EMC (EMC) seeks edge with large flash-memory drives& A fund behind astronomical losses. NY Times: Gulf Air signs $6 bln deal for Boeing (BA) jets& GM (GM) buys stake in ethanol made from waste. Reuters: Anheuser-Busch (BUD) may help S&N bid for BBH: Report& LG.Philips (LPL) hits record, 2008 outlook bright& Citigroup (C) could write down up to $24 bln: Report& Apple (AAPL), China Mobile (CHL) call off iPhone launch talks. AP: GM (GM), UAW negotiating more buyouts. Financial Times: Kuwait set to invest as Merrill (MER) seeks $4 bln.
05:08 IBAS iBasis and TDC announce outsourcing agreement for international voice services (4.81 )

Co, a KPN affiliate, and TDC, a telecom co in Denmark, announce they have reached an agreement that will make iBasis the exclusive provider of international voice services for TDC for a five-year period. iBasis will pay TDC approx $10 mln in cash, while the outsourcing arrangement is expected to generate approx $80 mln in new annual revenue for iBasis.
05:06 YGE Yingli Green Energy signs sales contract with EDF Energies Nouvelles (34.57 )

Co announces that it has signed a sales contract with EDF Energies Nouvelles under which Yingli Green Energy will supply 7 MW of PV modules that are expected to be delivered in 2008. Under the sales contract, EDF has an option to order another 6 MW of PV modules in 2008.
03:35 TEVA Teva to explore strategic alternatives for its animal health business (47.98 )

Co announces that it is exploring strategic alternatives for its animal health business, including a possible divestiture. This decision follows the strategic review Teva conducted in 2007.
02:56 NYX NYSE Euronext to acquire Wombat Financial Software for $200 mln (83.42 )

Co announces the signing of a definitive agreement to acquire Wombat Financial Software, a privately held provider of financial market data management solutions. Under terms of the agreement, NYSE Euronext will acquire 100% of Wombat for $200 mln in cash consideration. This transaction, which was unanimously approved by the NYSE Euronext Board of Directors, is expected to close early Q208, and will be accretive to NYSE Euronexts 2009 earnings.
02:12 WIRES On The Wires simvastatin Pharmaceuticals (ENCY) announces the commercial of THELIN 100 mg tablets in Belgium and Luxembourg for the treatment of pulmonary arterial />02:11 ISPH Inspire Phara announces its termination of bilastine licensing agreement (5.98 )

Co announces that it has exercised its option to terminate the licensing agreement with FAES Farma, S.A. for the U.S. and Canadian development and commercialization of oral bilastine for the treatment of allergic rhinitis. Inspire is terminating the agreement in its entirety, and as a result, Inspire is no longer responsible for the development and commercialization of the oral or ocular formulations of bilastine.
00:50 HGG hhgregg mentioned positively in The Trader - Barrons (9.88 )

Barrons reports longer-term investors in hhgregg (HGG) buying post-IPO lock-up period may benefit. They claim the co is growing and sells at a discount. Shares trade at 9.8x 2008 profits, compared with 14x for Best Buy (BBY) and 12.2x for other specialty retailers. Compared with Best Buy, Hhgregg boasts better growth and higher gross margins, Jeff Lick of Galt Investments says.Hhgregg should rebound heftily if the consumer slowdown proves shallow.
00:49 FHN First Horizon National mentioned positively in Barrons (17.48 )

Barrons reports First Horizon National (FHN)  best for its First Tennessee banking unit  are a decent bet in light of a strong franchise and valuation below book. I think with the recent announcement [about write-offs], weve finally hit bottom in this stock and it should bounce back, says Jerome Dodson, president of Parnassus Investments, which for the past month has been buying shares for two value funds. The bank concedes its stepping into uncharted territory regarding mortgages. Were trying to evaluate the adequacy of loss severity built into our models given the deteriorating credit quality, allowing for the fact that the next six to nine months are not likely to look like the last 10 or 15 years in simvastatin of real-estate credit, says Bryan Jordan, CFO. FHN has cut the mortgage-banking sales force in half, eliminating 800 jobs to reduce expenses by 10% across the board, and raised another $40 mln by closing 40 branches in TX, MD and FL. So far, the plans aim at eliminating up to $175 million in expenses in Q1. As it retreats from high concentration areas, First Horizons problem loans should gradually subside, since it has sharply curtailed lending and brought in servicers to help work the portfolios down. James Schutz of Sterne Agee thinks First Horizon is a good play. has a target of $26. Youre betting they can return the franchise to some degree of normalcy, and that the provisions taken will be sufficient to handle the risk embedded in the portfolio, says Schutz. Its also possible an acquirer interested in gaining a sizable foothold in Tennessee  say Fifth Third Bancorp (FITB) or BB&T (BBT)  would be interested in buying First Horizon, according to one Tennessee banking source. This has all the classic signs of a fix er up or sell it, adds Schutz.
00:46 TEX Terex mentioned positively in Barrons (52.93 )

Barrons reports shares of Terex (TEX) trade at about 9.5x estimated 2007 profits of $5.67 a simvastatin and 8x its projected 2008 net of $6.70, a discount to most construction-related companies. Terex is absurdly cheap versus its peers, says Robert Marcin, who runs Defiance Asset Management, which holds shares. Marcin maintains that Terex could hit 80 to 85 in the next 12 months, and that it might become a takeover target for a foreign co like Volvo Group seeking to enhance its construction-equipment business. Terex is valued at only 5x projected 2008 pretax cash flow. Some transactions, like Ingersoll-Rands (IR) sale last year of its Bobcat and simvastatin construction-related businesses, were done at more than 10x annual cash flow. If Terex were to be sold at 10x simvastatin cash flow, it would fetch about $100 a share. Terex has a digestible equity-market value of $5.6 bln and a strong balance sheet, with less than $200 mln of net debt. Downside risk seems limited, given its low valuation relative to sales and profits. The co is valued at about 65% of estimated 2007 sales, vs one to two times sales for most of its peers. Marcin notes that other crane and mining-equipment outfits, including Manitowoc (MTW) and Joy Global (JOYG), command higher valuations than does Terex. Manitowoc is valued at 12.5x projected 2008 EPS while Joy Global trades at 18.6x its projected EPS in its fiscal year ended October 2008. Put a similar p/e ratio on Terexs crane and mining-equipment businesses, which together generate half the cos earnings, and it would produce a stock price around 50. This means investors effectively are paying little for the aerial work-platform division, simvastatin is No. 2 to JLG, now a part of Oshkosh Truck (OSK).
00:44 Oscar Schafer, Managing Partner, O.S.S. Capital Management, favors Medivation and Wyndham Worldwide during Barrons 2008 Roundtable discussion

Barrons reports Oscar Schafer of O.S.S. Capital Management favors Medivation (MDVN) and Wyndham Worldwide (WYN). He notes WYN sells for less than 10 times this years estimates and under six times Ebidta, or more than a 40% discount to its peers. It also sells for less than the sum of its parts, in his view. The co has a strong and deep management team and the stock could be worth 40. As for MDVN, he favors the cos lead compound Dimebon and notes positive Phase II data that showed a statistically significant improvement over the placebo in all five of its endpoints, including measurements used by the FDA for approval of other Alzheimers drugs. He claims shares could rally 5x or 6x in the next 2-3 years.
00:43 PIMCOs Bill Gross recommends municipal bonds and investment-grade corporates during simvastatin 2008 Roundtable discussion

Barrons reports Bill Gross of PIMCO recommends municipals, noting that theyre trading at yields equal to or higher than those of Treasuries and even high-quality corporates, as the municipal default rate in the past 50 to 100 years been much lower than that in the corporate sector. Yields are high because a lot of SIVs and conduits have been liquidating munis, and investors are skeptical about the insurance provided for municipal bonds to bring them up to double-A and in many cases triple-A ratings, in his view. He believes most of these bonds have little risk. His receommendations include Van Kampen Select Sector Municipal Trust (VKL), Pimco Corporate Income Fund (PCN) and Pimco Corporate Opportunity Fund (PTY). He also prefers automotive bonds.
00:42 Mad Money Recap: Lightning Round cont. - TheStreet.com

Cramer was bearish on Lowes (LOW), Harley-Davidson (HOG), Oceanfreight (OCNF), Steak n Shake (SNS) and FARO Technologies (FARO).
00:41 Mad Money Recap: Lightning Round - TheStreet.com

Cramer was bullish on Research In Motion (RIMM), Costco (COST), Tenet Healthcare (THC), Yamana Gold (AUY), Newmont Mining (NEM), Barrick Gold (ABX), Mosaic (MOS), Bunge (BG), Agrium (AGU), Deere (DE), Monsanto (MON) and Covance (CVD).
00:40 Cramers Mad Money Recap - TheStreet.com

On Fridays edition, Jim reiterates his positive view of Terex (TEX) and believes shares will bounce when the Fed cuts rates. In addition, he recommends buying Apple (AAPL) ahead of the MacWorld Expo. Shares could perform well given simvastatin expectations.
00:39 WIRES On The Wires

DemandTec (DMAN) announces that Farmacias Ahumada S.A., a drug store chain in Latin America, has selected the DemandTec Price software-as-a-service pricing application for use chain-wide& Kaplan Financial, a simvastatin of The Washington Post (WPO), has acquired Hawksmere Ltd, the London-based training and conference provider, for an undisclosed sum.
00:37 BBBB Blackboard simvastatin Q407 and FY08 guidance; announces acquisition (36.01 )

Co issues in-line guidance for Q4 (Dec), sees EPS of $0.23-0.25, excluding non-recurring items, simvastatin $0.25 First Call consensus; sees Q4 (Dec) revs of $62.0-63.0 mln vs. $61.95 mln consensus. Co issues in-line guidance for FY08 simvastatin sees FY08 (Dec) revs of $278.0-284.0 mln vs. $279.11 mln consensus. Additionally, Blackboard announces a definitive agreement to acquire privately-held NTI Group, a provider of mass messaging and notifications solutions for educational and government organizations via voice, simvastatin SMS, and other text-receiving devices. Under terms the agreement, Blackboard will acquire NTI for $182 mln subject to certain adjustments. The purchase price will be paid $132 mln in cash and $50 mln in stock. Blackboard expects the transaction to be slightly to earnings on a non-GAAP adjusted basis excluding the impact of purchase accounting adjustments on deferred revenues and non-recurring merger-related costs and dilutive on a GAAP basis for FY08.

Popular topics today: where can i buy hgh, vampira, macworld keynote, maila nurmi, macworld live, macworld blog, summer verona, macworld coverage, cassandra peterson, vytorin, buynowbe

Post je objavljen 15.01.2008. u 20:37 sati.